186 related articles for article (PubMed ID: 8106229)
21. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
Ritchie S; Palmer S; Ellis-Pegler R
Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
[TBL] [Abstract][Full Text] [Related]
22. Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda.
Bachou H; Tylleskär T; Kaddu-Mulindwa DH; Tumwine JK
BMC Infect Dis; 2006 Nov; 6():160. PubMed ID: 17090299
[TBL] [Abstract][Full Text] [Related]
23. Blood culture Gram stain and simple clinical categorisation can be used to identify patients at risk for delay in appropriate antibiotic treatment.
Veijola S; Burtonwood M; Stapf J; Kauma H; Kauppila J; Koskela M; Hautala T
Int J Antimicrob Agents; 2008 Dec; 32(6):546-7. PubMed ID: 18789847
[No Abstract] [Full Text] [Related]
24. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
Ramphal R
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S25-31. PubMed ID: 15250017
[TBL] [Abstract][Full Text] [Related]
25. Bacteraemia in a tertiary care urban hospital in south India.
Chaudhury A; Rao TV
Indian J Pathol Microbiol; 1999 Jul; 42(3):317-20. PubMed ID: 10862291
[TBL] [Abstract][Full Text] [Related]
26. [Bacteremia in hematological malignant disorders].
Hammerstrøm J; Røym AL; Gran FW
Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1655-9. PubMed ID: 18704131
[TBL] [Abstract][Full Text] [Related]
27. Neonatal sepsis in hospital-born babies: bacterial isolates and antibiotic susceptibility patterns.
Aurangzeb B; Hameed A
J Coll Physicians Surg Pak; 2003 Nov; 13(11):629-32. PubMed ID: 14700488
[TBL] [Abstract][Full Text] [Related]
28. Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Murray CK; Walter EA; Crawford S; McElmeel ML; Jorgensen JH
Clin Infect Dis; 2001 May; 32(10):E140-2. PubMed ID: 11317266
[TBL] [Abstract][Full Text] [Related]
29. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003].
Bertrand X; Costa Y; Pina P
Med Mal Infect; 2005 Jun; 35(6):329-34. PubMed ID: 16039819
[TBL] [Abstract][Full Text] [Related]
30. Changing pattern of neonatal bacteremia. Microbiology and antibiotic resistance.
Ellabib MS; Ordonez A; Ramali A; Walli A; Benayad T; Shebrlo H
Saudi Med J; 2004 Dec; 25(12):1951-6. PubMed ID: 15711674
[TBL] [Abstract][Full Text] [Related]
31. Intravenous catheter infections associated with bacteraemia: a 2-year study in a university hospital.
Paragioudaki M; Stamouli V; Kolonitsiou F; Anastassiou ED; Dimitracopoulos G; Spiliopoulou I
Clin Microbiol Infect; 2004 May; 10(5):431-5. PubMed ID: 15113321
[TBL] [Abstract][Full Text] [Related]
32. [Bacterial resistance and management of nosocomial infections: relations to hematology].
Ladeb S; Durand-Gasselin B; Leclercq R; Astier A; Cordonnier C
Pathol Biol (Paris); 1996 Feb; 44(2):107-12. PubMed ID: 8761595
[TBL] [Abstract][Full Text] [Related]
33. [Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Sfax-Tunisia (1993-1998)].
Ben Jemaa Z; Mahjoubi F; Ben Haj H'mida Y; Hammami N; Ben Ayed M; Hammami A
Pathol Biol (Paris); 2004 Mar; 52(2):82-8. PubMed ID: 15001236
[TBL] [Abstract][Full Text] [Related]
34. Bacteraemia in febrile neutropenic cancer patients.
Klastersky J; Ameye L; Maertens J; Georgala A; Muanza F; Aoun M; Ferrant A; Rapoport B; Rolston K; Paesmans M
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S51-9. PubMed ID: 17689933
[TBL] [Abstract][Full Text] [Related]
35. [Bacteremia with granulocytopenia--microbiology and empiric antibiotic treatment].
Hammerstrøm J; Jacobsen T
Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4370-5. PubMed ID: 9889610
[TBL] [Abstract][Full Text] [Related]
36. Bacteraemia--a Sagamu perception.
Osinupebi OA; Olajubu FA
Afr J Med Med Sci; 2003 Sep; 32(3):311-4. PubMed ID: 15030095
[TBL] [Abstract][Full Text] [Related]
37. Optimizing antimicrobial therapy for gram-positive bloodstream infections in patients on hemodialysis.
Pai AB; Pai MP
Adv Chronic Kidney Dis; 2006 Jul; 13(3):259-70. PubMed ID: 16815231
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibility profiles of clinically relevant blood culture isolates from nine surgical intensive care units, 1996-2000.
Assadian O; Apfalter P; Assadian A; Makristathis A; Daxboeck F; Koller W; Hirschl AM
Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):743-7. PubMed ID: 12415474
[TBL] [Abstract][Full Text] [Related]
39. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
40. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial.
Rijnders BJ; Van Wijngaerden E; Vandecasteele SJ; Stas M; Peetermans WE
J Antimicrob Chemother; 2005 Jan; 55(1):90-4. PubMed ID: 15574481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]